Advertisement
Screener

ProKidney Corp. (PROK) Material Contracts

ProKidney Corp. Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2026-08-10: Form 10-Q; Exhibit 10.1; Description Employment Agreement, dated as of May 18, 2026 by and between Kenneth Locke and ProKidney, LLC..
  • 2026-03-18: Form 10-K; Exhibit 10.25; Description Purchase and Sale Agreement by and between the ProKidney Acquisition Company, LLC and Northpoint Development Group, LLC, dated October 17, 2025..
  • 2026-03-18: Form 10-K; Exhibit 10.11; Description ProKidney Corp. Non-Employee Director Compensation Policy, as amended..
  • 2026-03-18: Form 10-K; Exhibit 10.6; Description ProKidney Short Term Incentive Performance Plan..
FiledFormExhibitDescription
2026-08-1010-Q10.1Employment Agreement, dated as of May 18, 2026 by and between Kenneth Locke and ProKidney, LLC.
2026-03-1810-K10.25Purchase and Sale Agreement by and between the ProKidney Acquisition Company, LLC and Northpoint Development Group, LLC, dated October 17, 2025.
2026-03-1810-K10.11ProKidney Corp. Non-Employee Director Compensation Policy, as amended.
2026-03-1810-K10.6ProKidney Short Term Incentive Performance Plan.
2025-08-1210-Q10.11Employment Agreement, dated as of June 11, 2025 by and between Darin Weber and ProKidney, LLC.
2025-08-1210-Q10.10Employment Agreement, dated as of May 9, 2025 by and between Todd Girolamo and ProKidney, LLC.
2025-08-1210-Q10.9Employment Agreement, dated as of May 12, 2025 by and between James Coulston and ProKidney, LLC.
2025-08-1210-Q10.8Employment Agreement, dated as of May 12, 2025 by and between Bruce Culleton, M.D. and ProKidney, LLC.
2025-03-1710-K10.23Employment Agreement, dated April 11, 2023, by and between ProKidney, LLC and Todd Girolamo.
2025-03-1710-K10.22Assignment and Assumption of Purchase and Sale Agreement, dated November 25, 2024, by and among ProKidney Acquisition Company, LLC. and ProKidney Acquisition Company II, LLC.
2025-03-1710-K10.21Pro-Kidney Corp. Non-Employee Director Compensation Policy, as amended.
2025-03-1710-K10.20Purchase and Sale Agreement by and between the ProKidney Acquisition Company, LLC and Breit SE Industrial Propco NC LP, dated November 20, 2024.
2024-06-138-K10.1Form of Share Purchase Agreement by and between the Company and certain investors, dated June 11, 2024.
2024-05-1010-Q10.5Pro-Kidney Corp. Non-Employee Director Compensation Policy.
2024-03-258-K10.1Employment Agreement, dated March 25, 2024, by and between ProKidney, LLC and Ulrich Ernst.
2024-03-2210-K10.5Second Amended and Restated Limited Partnership Agreement for a Limited Partnership Called ProKidney LP, dated as of July 11, 2022, as amended as of November 14, 2023, by and among Tolerantia, LLC, Control Empresarial de Capitales, S.A. de C.V., ProKidney Management Equity LLC, ProKidney Corp. (formerly known as Social Capital Suvretta Holdings Corp. III), ProKidney Corp. GP Limited and ProKidney GP Limited.
2024-03-188-K/A10.1Separation Agreement, dated March 13, 2024, by and between ProKidney, LLC and Deepak Jain, Ph.D
2024-03-188-K/A10.2Separation Agreement, dated March 13, 2024, by and between ProKidney, LLC and Tim Bertram, Ph.D.
2023-12-058-K/A10.1Employment Agreement, dated December 3, 2023, by and between ProKidney, LLC and Bruce Culleton.
2023-08-1010-Q10.2Assignment and Assumption of Purchase and Sale Agreement, dated July 17, 2023, by and among ProKidney Corp. and ProKidney Acquisition Company, LLC.
2023-08-1010-Q10.1Purchase Agreement, as amended, dated March 29, 2023, by and among ProKidney Corp. and 73 BCI 2 LLC.
2023-03-2810-K10.31Consulting Services Agreement, dated as of January 1, 2020 between ProKidney, LLC (formerly known as Twin City Bio LLC) and Nefro Health.
2023-03-2810-K10.30Consulting Services Agreement, dated as of January 1, 2020 between ProKidney (formerly known as RegenMed (Cayman) Ltd. (d/b/a inRegen)) and Nefro Health.
2023-03-2810-K10.20ProKidney Corp. 2022 Director Compensation Policy
2023-03-2810-K10.19Incentive Stock Option Award Agreement, dated as of October 20, 2022, by and between Dr. Timothy Bertram and ProKidney Corp.
2023-03-2810-K10.18Form of Employee Incentive Stock Option Award
2023-03-2810-K10.17Form of Director Stock Option Award
2023-03-2810-K10.16Employment Agreement, dated as of December 3, 2022 by and between Dr. Joseph Stavas and ProKidney, LLC
2023-03-2810-K10.15Employment Agreement, dated as of December 2, 2022 by and between Dr. Deepak Jain and ProKidney, LLC
2023-03-2810-K10.14Employment Agreement, dated as of December 3, 2022 by and between James Coulston and ProKidney, LLC
2023-03-2810-K10.13Employment Agreement, dated as of December 3, 2022, by and between Dr. Timothy Bertram and ProKidney, LLC
2023-01-198-K10.1ProKidney Short Term Incentive Performance Plan
2022-07-158-K10.13Form of Indemnification Agreement, dated as of July 11, 2022, by and among ProKidney Corp. and its directors and executive officers.
2022-07-158-K10.12ProKidney Corp. Employee Stock Purchase Plan.
2022-07-158-K10.11ProKidney Corp. 2022 Incentive Equity Plan.
2022-07-158-K10.5Second Amended and Restated Limited Partnership Agreement for a Limited Partnership Called ProKidney LP, dated as of July 11, 2022, by and among Tolerantia, LLC, Control Empresarial de Capitales, S.A. de C.V., ProKidney Management Equity LLC, ProKidney Corp. (formerly known as Social Capital Suvretta Holdings Corp. III), ProKidney Corp. GP Limited and ProKidney GP Limited.
2022-07-158-K10.4Amended and Restated Registration Rights Agreement, dated as of July 11, 2022, by and among ProKidney Corp. (formerly known as Social Capital Suvretta Holdings Corp. III), SCS Sponsor III LLC, the ProKidney Holders (as defined therein), Marc Semigran, Uma Sinha, Sukumar Nagendran, David Spiegel and the Investor Stockholders (as defined therein).
2022-07-158-K10.3Lock-up Agreement, dated as of July 11, 2022, by and among ProKidney Corp. (formerly known as Social Capital Suvretta Holdings Corp. III), SCS Sponsor III LLC, the Sponsor Key Holders (as defined therein) and the ProKidney Holders (as defined therein).
2022-07-158-K10.2Exchange Agreement, dated as of July 11, 2022, by and among ProKidney Corp. (formerly known as Social Capital Suvretta Holdings Corp. III), ProKidney LP, acting through its general partner ProKidney Corp. GP Limited, and certain holders named therein.
2022-07-158-K10.1Tax Receivable Agreement, dated as of July 11, 2022, by and among ProKidney Corp. (formerly known as Social Capital Suvretta Holdings Corp. III), the TRA Party Representative (as defined therein) and the TRA Parties (as defined therein).
2022-04-228-K10.1Promissory Note, dated April 20, 2022
2022-01-218-K/A10.4ProKidney Unitholder Support Agreement, dated as of January 18, 2022
2022-01-218-K/A10.3Sponsor Support Agreement, dated as of January 18, 2022
2022-01-218-K/A10.2Form of Subscription Agreement for Individual Investors
2022-01-218-K/A10.1Form of Subscription Agreement for Institutional Investors
2021-09-248-K10.3Director Restricted Stock Unit Award Agreement, dated September 24, 2021, between the Company and Dr. Sinha.
2021-09-248-K10.2Indemnity Agreement, dated September 24, 2021, between the Company and Dr. Sinha.
2021-09-248-K10.1Letter Agreement, dated September 24, 2021, between the Company and Dr. Sinha.
2021-07-028-K10.6Form of Indemnity Agreement, dated June 29, 2021, between the Company and each of its officers and directors.
2021-07-028-K10.5Private Placement Shares Purchase Agreement, dated as of June 29, 2021, between the Company and the Sponsor.
2021-07-028-K10.4Administrative Services Agreement, dated as of June 29, 2021, between the Company and Social + Capital Partnership, LLC.
2021-07-028-K10.3Registration Rights Agreement, dated as of June 29, 2021, among the Company and certain other security holders named therein.
2021-07-028-K10.2Investment Management Trust Agreement, dated as of June 29, 2021, between the Company and Continental Stock Transfer & Trust Company, as trustee.
2021-07-028-K10.1Letter Agreement, dated as of June 29, 2021, among the Company, the Sponsor and the Company’s officers and directors.